Table III.

Comparison of SARS-CoV-2 vaccines and excipients

Vaccine	Availability	Vaccine type	Excipients
CoronaVac (Sinovac, China)	Brasil, China (essential workers and high-risk groups), Indonesia, Turkey	Inactivated vaccine (formalin with alum adjuvant)	Aluminum hydroxide, disodium hydrogen phosphate, sodium dihydrogen phosphate, sodium chloride
Convidicea Ad5-nCoV (CanSino Biologics, Beijing Inst. Biotech., NPO Petrovax)	China (limited to military use only), Mexico, Pakistan	Recombinant adenovirus type 5 vector against spike RBD protein	NA
BBIBP-CorV (Sinopharm, Beijing Institute and Wuhan Institute of Biological Products)	China, Bahrain, Egypt, United Arab Emirates	Inactivated SARS-CoV-2 (vero cells) + aluminum hydroxide adjuvant	Aluminum hydroxide, disodium hydrogen phosphate, sodium dihydrogen phosphate, sodium chloride, sodium hydroxide, sodium bicarbonate, M199
Pfizer-BioNTech BNT162b2	Argentina, Australia, Bahrain, Canada, Chile, Costa Rica, Ecuador, European Union, Israel, Japan, Jordan, Kuwait, Mexico, Oman, Panama, Saudi Arabia, Singapore, Switzerland, United Kingdom, United States, WHO.	mRNA-based vaccine (encoding the viral spike (S) glycoprotein)	(4-hydroxybutyl) azanediyl)bis (hexane-6,1-diyl)bis(2-hexyldecanoate)] (ALC-0315), 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide (ALC-0159),1,2-Distearoyl-sn-glycero-3-phosphocholine cholesterol, potassium chloride, potassium dihydrogen phosphate, sodium chloride, disodium hydrogen phosphate dihydrate, sucrose, water for injection
Moderna mRNA-1273	Canada, European Union, Israel, Switzerland, United Kingdom, United States	mRNA-based vaccine (encoding the prefusion stabilized spike (S) glycoprotein)	Lipids (SM-102, 1,2-dimyristoyl-rac-glycero3-methoxypolyethylene glycol-2000 [PEG2000-DMG], cholesterol, and 1,2-distearoyl-snglycero-3-phosphocholine [DSPC]), tromethamine, tromethamine hydrochloride, acetic acid, sodium acetate, and sucrose
ChAdOx1 (Oxford/AstraZeneca; Covishield in India)	Argentina, Australia, Canada, Dominican Republic, El Salvador, European Union, India, Mexico, Morocco, United Kingdom	Replication-deficient viral vector vaccine (adenovirus from chimpanzees)	L-Histidine, L-histidine hydrochloride monohydrate, magnesium chloride hexahydrate, polysorbate 80, ethanol, sucrose, sodium chloride, disodium edetate dihydrate, water for injection
Covaxin (BBV152) (Bharat Biotech, India)	India	Inactivated vaccine	NA
Sputnik V (Gamaleya Research Institute)	Russia, Palestine	Nonreplicating, 2-component vector (adenovirus) against spike (S) glycoprotein	Tris (hydroxymethyl) aminomethane, sodium chloride, sucrose, magnesium chloride hexahydrate, sodium EDTA, polysorbate 80, ethanol, water for injection
EpiVacCorona (Federal Budgetary Research Institution State Research Ctr, Russia)	Russia	Peptide vaccine with alum adjuvant	Aluminum hydroxide, potassium dihydrogen phosphate, potassium chloride, sodium hydrogen phosphate dodecahydrate, sodium chloride, water for injection

EDTA, Ethylenediaminetetraacetic acid; NA, Not applicable; RBD, receptor binding domain; WHO, World Health Organization,

Adapted with permission from Turner PJ, Ansotegui IJ, Campbell DE, Cardona V, Ebisawa M, El-Gamal Y, et al. COVID-19 vaccine-associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organ J 2021;14:100517.⁴